文献速递流行病学与生物统计临床试验与 GCP

中国随机药物试验中主要结局指标切换与报告结果之间的关联

Association between switching of primary outcomes and reported trial findings among randomized drug trials from China.
PubMed 文献 · J Clin Epidemiol · 2020-12-09

该回顾性队列研究检索截至2019年8月的中国随机对照试验注册库及对应期刊论文,评估注册主要结局指标切换与结果性质的关系。294项试验中131项(45%)发生主要结局切换;阴性结果的注册主要结局被切换为次要结局的比值比在预先注册试验中为2.64(95%CI 1.16-6.02),在研究进行中注册的试验中为8.84(95%CI 3.62-25.93)。结论提示结果性质可能影响预设主要结局被后续切换的可能性。

要点

  • 中国随机药物试验中45%(131/294)存在注册主要结局切换。
  • 阴性结果的主要结局更易被切换为次要结局,进行中注册试验尤为明显。
  • 结果性质可能影响预设主要结局的后续报告方式。

核心结论

  • 结果性质可能影响预设主要结局被后续切换的可能性。

研究设计与样本

  • 回顾性队列研究,从试验注册库检索截至2019年8月的中国随机对照试验,并匹配期刊论文。

主要发现

  • 294项随机对照试验中131项(45%)发生注册主要结局切换。
  • 450个注册主要结局在期刊论文中匹配到522个(37%)主要结局和871个(63%)次要结局。
  • 预先注册试验中,阴性结果主要结局被切换的比值比为2.64(95%CI 1.16-6.02)。
  • 进行中注册试验中,阴性结果主要结局被切换的比值比为8.84(95%CI 3.62-25.93)。

临床怎么用

  • 报告随机对照试验时应严格遵循注册的主要结局,避免因结果阴性而切换结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: To evaluate the association between the nature of findings and the switching of registered primary outcomes among randomized controlled trials (RCTs) from mainland China. METHODS: This is a retrospective cohort study. We retrieved RCTs from trial registries and identified the corresponding journal articles from bibliographic databases until August 2019. Trial registries and journal articles were compared to evaluate whether registered primary outcomes with negative findings were more likely to be switched to secondary outcomes in the subsequent journal articles than those with positive findings. RESULTS: Switching of registered primary outcomes occurred in 131 (45%) of 294 RCTs. A total of 450 registered primary outcomes were matched to 522 (37%) primary outcomes and 871 (63%) secondary outcomes in the journal articles. Among RCTs registered before they started, the odds of switching primary outcomes with negative findings were 2.64 (95% CI: 1.16-6.02) times the odds of switching those with positive findings. Among RCTs registered when they were ongoing, the odds of switching primary outcomes with negative findings were 8.84 (95% CI: 3.62-25.93) times the odds of switching those with positive findings. CONCLUSION: The nature of findings may play a role in how likely a prespecified primary outcome is switched subsequently.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Jia Y, Huang D, Wen J, et al. Association between switching of primary outcomes and reported trial findings among randomized drug trials from China. J Clin Epidemiol. 2020. PMID: 33309887. doi:10.1016/j.jclinepi.2020.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。